ACVA Stock Soars As Copart Launches $10.50 Cash Takeover

ACV Auctions Inc. stocks have been trading up by 44.53 percent amid strong marketplace growth and improving profitability expectations.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading ACVA

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Copart agreed to buy ACV Auctions for $10.50 per share in cash, a roughly 41–45% premium that values ACVA at around $1.9–$2.0B.
The deal, approved by both boards, uses a tender offer and merger structure, with closing targeted by year-end 2026 and ACV operating as an independent Copart subsidiary.
Takeover headlines sent ACV Auctions shares up about 43% to $10.32, re-rating ACVA toward the proposed deal price almost overnight.
Law firm Halper Sadeh LLC is probing whether ACV’s board secured a fair price in the Copart transaction, spotlighting potential conflicts and valuation questions.
Before the M&A news, Citi had lifted its ACV Auctions price target to $8.50 with a Neutral rating, well below Copart’s $10.50 offer.

Live Update At 07:47:25 EDT: On Friday, September 11, 2026 ACV Auctions Inc. stock [NYSE: ACVA] is trending up by 44.53%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

ACV Auctions, trading under ticker ACVA, has turned into a classic merger-arb story, but the fundamentals still matter for traders watching deal risk. On the daily chart, ACVA spent weeks stuck in a tight $6.70–$7.70 range, with closes mostly between $6.70 and $7.60. The trend was choppy, not trending hard in either direction.

Then the Copart deal dropped. ACV Auctions ripped from the low-$7s to $10.32, a 43% surge that instantly reset the trading range. On the intraday tape, ACVA is now pinned around $10.35–$10.43 with very small 5‑minute candles. That tight band tells traders the market is treating $10.50 as the anchor.

More Breaking News

Financially, ACV Auctions is still a growth-at-a-loss name. Revenue runs near $760M annually and has been growing above 20% a year, but margins are negative across the board. ACVA posts a gross margin above 60%, yet EBIT margin sits around -6% and net margins near -8%. Cash burn is real: free cash flow in the latest quarter was roughly -$47M, with operating cash flow at about -$35M. Balance sheet strength helps; ACV has about $242M in cash, current ratio near 1.5, and moderate leverage, which supports deal credibility. Traders should see ACVA as a premium-priced asset, not a deep-value turnaround.

Why Traders Are Watching ACVA Right Now

ACV Auctions has jumped to the front of every M&A scanner. Copart’s all‑cash offer of $10.50 per ACVA share represents about a 45% premium to the pre‑rumor price and around a 41% premium to the 30‑day volume‑weighted average. For active traders, that offer price is now the key line on the chart. ACVA is trading only a few cents below it, turning the stock into a spread game.

The news flow built in stages. First came reports that Copart was near a deal to acquire ACV Auctions at an equity value close to $2B. That headline alone sent ACVA up 43%, with the stock spiking to $10.32 as traders rushed to price in the takeover. Bloomberg coverage framed it as a “near deal,” and the market immediately re‑rated ACVA toward that expected value.

Then the official confirmation hit: ACV Auctions agreed to the $10.50 all‑cash bid, valuing the company around $1.9B, with both boards voting unanimously. ACV will stay under its current leadership as an independent Copart subsidiary, which often reduces execution worries. For day traders, that combination—clear price, board support, strategic logic—usually compresses volatility after the initial spike.

But ACVA is not risk‑free. Halper Sadeh, an investor‑rights firm, opened an investigation into whether ACV’s board left money on the table. That kind of headline can create small bouts of volatility as merger‑arb desks handicap the odds of a bump in price, delay, or extra disclosures. At the same time, Citi’s earlier $8.50 target on ACV Auctions highlights that $10.50 already sits well above at least one major analyst’s view, which supports the fairness narrative. For now, ACVA trades like a deal‑spread instrument, not a pure growth story.

Conclusion

For traders, ACV Auctions is a live case study in how fast a sleepy chart can turn explosive on M&A news. ACVA spent weeks grinding sideways in the $7s with weak profitability, negative returns on equity, and steady cash burn. The business was growing, but the market was far from euphoric. One takeover headline from Copart, and ACVA instantly repriced near $10.50 per share, adding roughly $600M–$700M in equity value in a single move.

From here, every ACV Auctions trade is about risk versus reward around that $10.50 line. Upside is effectively capped by the offer. Downside sits wherever traders think the stock would land if the deal breaks, likely closer to the pre‑deal $7–$8 range given Citi’s $8.50 target. Legal noise from Halper Sadeh adds headline risk, but it also signals some shareholders believe ACVA is worth even more, which keeps a small optionality premium in the stock.

This is exactly the type of setup Tim Sykes and many short‑term traders study: a catalyst, a defined range, and a clear thesis to test. As Tim Sykes likes to say, “The market rewards prepared traders who react, not predict.” That kind of preparation doesn’t happen randomly—As Tim Bohen, lead trainer with StocksToTrade says, “A consistent trading routine beats sporadic action every time. Show up daily, and you’ll start to see the patterns others miss.” ACV Auctions is now a textbook M&A trading classroom—where discipline, tight risk control, and respect for news flow will matter more than ever.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!